Brind.

Mark Costar holds AstraZeneca in his portfolio and is quizzed about Nvidia. He also holds HSBC. AstraZeneca is listed on the London Stock Exchange.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Mark AstraZeneca Nvidia HSBC

Keep exploring

The entities involved

Mark
researcher ORCID ID = 0000-0002-4304-1174
- Mark Sohaney was appointed senior vice president at the University of Maryland Global Campus.Mon 19:24
- Mark served as lead trial counsel for the State of Ohio.Mon 18:26
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Sat 16:57
- Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.Sat 07:38
Nvidia
American multinational technology company
- AAII members were advised to consider Nvidia as an investment opportunity.08:41
- Nvidia is supplying GPUs for SpaceX's AI segment, while financial partners like Goldman Sachs mobilize capital for the AI buildout.08:28
HSBC
British multinational bank
- HSBC reissued a reduced rating on shares of Stellantis Group.08:00
- Several financial stocks, including FirstCash, UWM, and HSBC, showed mixed performance following recent earnings reports.Sat 19:45

Coverage

Newest first; wire copies grouped

Jul 21dailymail.com